- Filed
- Nov 13, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Nov 6, 2025 | 46.27M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 47.59M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 44.79M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 42.79M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 38.3M sh |
| Capex | Q3 2025 · Sep 30, 2025 | $196K |
| Capex restated | Q3 2025 · Sep 30, 2024 | $205K |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | −$116.88M |
| Operating Cash Flow restated | Q3 2025 · Sep 30, 2024 | −$55.7M |
| Long Term Debt | Q3 2025 · Sep 30, 2025 | $137.22M |
| Short Term Investments | Q3 2025 · Sep 30, 2025 | $380.73M |
| Short Term Investments | Q3 2025 · Dec 31, 2024 | $212.59M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $74.25M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $22.52M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | $116.96M |
| Stockholders Equity | Q3 2025 · Jun 30, 2025 | $44.38M |
| Stockholders Equity | Q3 2025 · Mar 31, 2025 | $86.67M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $115.62M |
| Stockholders Equity restated | Q3 2025 · Sep 30, 2024 | $149.71M |
| Stockholders Equity restated | Q3 2025 · Jun 30, 2024 | $176.69M |
| Stockholders Equity restated | Q3 2025 · Mar 31, 2024 | $133.74M |
| Stockholders Equity restated | Q3 2025 · Dec 31, 2023 | $139.77M |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $38.79M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $31.72M |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $359.04M |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $129.5M |
| Current Assets | Q3 2025 · Sep 30, 2025 | $475.5M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $244.57M |
| Total Assets | Q3 2025 · Sep 30, 2025 | $476M |
| Total Assets | Q3 2025 · Dec 31, 2024 | $245.12M |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$0.92 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$2.81 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | −$0.70 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | −$1.96 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$0.92 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$2.81 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | −$0.70 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | −$1.96 |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $34.92M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $107.36M |
| Rd Expense restated | Q3 2025 · Sep 30, 2024 | $27.59M |
| Rd Expense restated | Q3 2025 · Sep 30, 2024 | $70.73M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$43.8M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$126.07M |
| Net Income | Q3 2025 · Jun 30, 2025 | −$45.27M |
| Net Income | Q3 2025 · Mar 31, 2025 | −$37M |
| Net Income restated | Q3 2025 · Sep 30, 2024 | −$29.79M |
| Net Income restated | Q3 2025 · Sep 30, 2024 | −$75.13M |
| Net Income restated | Q3 2025 · Jun 30, 2024 | −$23.72M |
| Net Income restated | Q3 2025 · Mar 31, 2024 | −$21.61M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$42.85M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$122.99M |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | −$30.06M |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | −$76.84M |